Prognostic implication of CD274 (PD-L1) protein expression in tumor-infiltrating immune cells for microsatellite unstable and stable colorectal cancer (Q38730936)

From Wikidata

Jump to navigation Jump to search

scientific article published on 12 April 2017

Language	Label	Description	Also known as
English	Prognostic implication of CD274 (PD-L1) protein expression in tumor-infiltrating immune cells for microsatellite unstable and stable colorectal cancer	scientific article published on 12 April 2017

Statements

scholarly article

1 reference

Europe PubMed Central

5 September 2017

Prognostic implication of CD274 (PD-L1) protein expression in tumor-infiltrating immune cells for microsatellite unstable and stable colorectal cancer (English)

1 reference

Europe PubMed Central

5 September 2017

colorectal cancer

1 reference

based on heuristic

inferred from title

tumor-infiltrating immune cell

1 reference

based on heuristic

inferred from title

author name string

Kyu Sang Lee

1

1 reference

Europe PubMed Central

5 September 2017

Yoonjin Kwak

2

1 reference

Europe PubMed Central

5 September 2017

Soyeon Ahn

3

1 reference

Europe PubMed Central

5 September 2017

Eun Shin

4

1 reference

Europe PubMed Central

5 September 2017

Heung-Kwon Oh

5

1 reference

Europe PubMed Central

5 September 2017

Duck-Woo Kim

6

1 reference

Europe PubMed Central

5 September 2017

Sung-Bum Kang

7

1 reference

Europe PubMed Central

5 September 2017

Gheeyoung Choe

8

1 reference

Europe PubMed Central

5 September 2017

Woo Ho Kim

9

1 reference

Europe PubMed Central

5 September 2017

Hye Seung Lee

10

1 reference

Europe PubMed Central

5 September 2017

publication date

12 April 2017

1 reference

Europe PubMed Central

5 September 2017

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

5 September 2017

66

1 reference

Europe PubMed Central

5 September 2017

927-939

1 reference

Europe PubMed Central

5 September 2017

7

1 reference

Europe PubMed Central

5 September 2017

https://scigraph.springernature.com/pub.10.1007/s00262-017-1999-6

0 references

Antagonist antibodies to PD-1 and B7-H1 (PD-L1) in the treatment of advanced human cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

PD-L1 expression in colorectal cancer is associated with microsatellite instability, BRAF mutation, medullary morphology and cytotoxic tumor-infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Characterisation of PD-L1-positive subsets of microsatellite-unstable colorectal cancers

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

PD-L1 and Survival in Solid Tumors: A Meta-Analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Clinical impact of programmed cell death ligand 1 expression in colorectal cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Significance of Programmed Death Ligand 1 (PD-L1) Immunohistochemical Expression in Colorectal Cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Patterns and prognostic relevance of PD-1 and PD-L1 expression in colorectal carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Tumour CD274 (PD-L1) expression and T cells in colorectal cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Histopathological identification of colon cancer with microsatellite instability

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Protein expression profiling and molecular classification of gastric cancer by the tissue array method.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

BRAFV600E immunohistochemistry facilitates universal screening of colorectal cancers for Lynch syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

BRAF, PIK3CA, and HER2 Oncogenic Alterations According to KRAS Mutation Status in Advanced Colorectal Cancers with Distant Metastasis

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

How to read a paper. Statistics for the non-statistician. I: Different types of data need different statistical tests

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Clinicopathologic profile, immunophenotype, and genotype of CD274 (PD-L1)-positive colorectal carcinomas.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Somatic mutation profiles of MSI and MSS colorectal cancer identified by whole exome next generation sequencing and bioinformatics analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

An immunogenomic stratification of colorectal cancer: Implications for development of targeted immunotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Characterization of an adaptive immune response in microsatellite-instable colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Cancer immunoediting from immune surveillance to immune escape

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Prognostic effect of different PD-L1 expression patterns in squamous cell carcinoma and adenocarcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Association of PD-L1 expression on tumor-infiltrating mononuclear cells and overall survival in patients with urothelial carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Development of PD-1/PD-L1 Pathway in Tumor Immune Microenvironment and Treatment for Non-Small Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Immune cells: plastic players along colorectal cancer progression

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Differential Expression of PD-L1 between Primary and Metastatic Sites in Clear-Cell Renal Cell Carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Molecular phenotypes of colorectal cancer and potential clinical applications

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Association of PD-L1 overexpression with activating EGFR mutations in surgically resected nonsmall-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

PD-L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti-PD-1/PD-L1 clinical trials

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Comparative study of the PD-L1 status between surgically resected specimens and matched biopsies of NSCLC patients reveal major discordances: a potential issue for anti-PD-L1 therapeutic strategies

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1999-6

21 January 2018

Identifiers

10.1007/S00262-017-1999-6

1 reference

Europe PubMed Central

5 September 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

5 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38730936&oldid=1781315502"